Sequencing giant Illumina Inc. ILMN is set to release third-quarter 2024 results on Nov. 4 after the closing bell. Stay up-to ...

Bio-Rad Laboratories, Inc. has developed partnerships with innovative next-generation sequencing instrument providers and announces compatibility of the SEQuoia RNA Sequencing Library Preparation ...

The Genomics Core now has an Illumina NextSeq500 Next Generation Sequencing (NGS) instrument! This will expand our capacity of services already offered for NGS. Feel free to call or email us to find ...

The Bristol Genomics Facility has the capacity to run both high output and low output next generation sequencing ... lengths generally suited to the sequencing of small genomes, amplicons and targeted ...

For more information on Quantum-Si's technology and research applications, please visit The Protein Sequencing Company™ | Quantum-Si ...

Illumina's margin expansion and a coming revenue recovery should help the stock multiples re-rate toward life science ...

These decision points help guide scientists towards deciding on the ideal instrument to purchase according to their individual laboratory’s unique goals. However, oftentimes researchers face competing ...

Designed to make next-generation sequencing accessible to more labs SAN DIEGO, Oct. 24, 2024 /PRNewswire/ -- Illumina, Inc.

The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. The PX Instrument combines single cell and spatial analysis ...

Microbiome diagnostics industry is projected to witness a CAGR of 13.4% during the period 2024-2032. This growth can be ...

Login online to reserve instrument time, training ... See the NERVE facilities. Next Generation Sequencing, Genomics & Bioinformatics Lab The Next Generation Sequencing, Genomics & Bioinformatics Lab ...

TD Cowen analyst Daniel Brennan maintained a Buy rating on Illumina (ILMN – Research Report) today and set a price target of $177.00.